A critique of the hypothesis that CA repeats are primary targets of neuronal MeCP2

Using relevant neuronal datasets and in vitro experiments, we show that MeCP2 function depends on methylated CAC (mCAC) sites regardless of their occurrence in CA repeats or elsewhere in the genome. The DNA-binding protein MeCP2 is reported to bind methylated cytosine in CG and CA motifs in genomic DNA, but it was recently proposed that arrays of tandemly repeated CA containing either methylated or hydroxymethylated cytosine are the primary targets for MeCP2 binding and function. Here we investigated the predictions of this hypothesis using a range of published datasets. We failed to detect enrichment of cytosine modification at genomic CA repeat arrays in mouse brain regions and found no evidence for preferential MeCP2 binding at CA repeats. Moreover, we did not observe a correlation between the CA repeat density near genes and their degree of transcriptional deregulation when MeCP2 was absent. Our results do not provide support for the hypothesis that CA repeats are key mediators of MeCP2 function. Instead, we found that CA repeats are subject to CAC methylation to a degree that is typical of the surrounding genome and contribute modestly to MeCP2-mediated modulation of gene expression in accordance with their content of this canonical target motif.

[1]  Mitchell R. Vollger,et al.  From telomere to telomere: the transcriptional and epigenetic state of human repeat elements , 2021, bioRxiv.

[2]  S. Dimitrov,et al.  MeCP2 is a microsatellite binding protein that protects CA repeats from nucleosome invasion , 2021, Science.

[3]  R. Kohli,et al.  TET-TDG active DNA demethylation at CpG and non-CpG sites. , 2021, Journal of molecular biology.

[4]  C. W. Ragsdale,et al.  The emergence of the brain non-CpG methylation system in vertebrates , 2021, Nature Ecology & Evolution.

[5]  A. Bird,et al.  Neuronal non-CG methylation is an essential target for MeCP2 function , 2020, bioRxiv.

[6]  H. Zoghbi,et al.  Losing Dnmt3a dependent methylation in inhibitory neurons impairs neural function by a mechanism impacting Rett syndrome , 2020, eLife.

[7]  B. Waclaw,et al.  Absence of MeCP2 binding to non-methylated GT-rich sequences in vivo , 2020, Nucleic acids research.

[8]  Eric C. Griffith,et al.  MeCP2 Represses the Rate of Transcriptional Initiation of Highly Methylated Long Genes. , 2019, Molecular cell.

[9]  Thomas Manke,et al.  snakePipes: facilitating flexible, scalable and integrative epigenomic analysis , 2019, Bioinform..

[10]  R. Tjian,et al.  MeCP2 nuclear dynamics in live neurons results from low and high affinity chromatin interactions , 2019, bioRxiv.

[11]  J. Min,et al.  Plasticity at the DNA recognition site of the MeCP2 mCG-binding domain , 2019, bioRxiv.

[12]  B. Waclaw,et al.  Quantitative modelling predicts the impact of DNA methylation on RNA polymerase II traffic , 2019, Proceedings of the National Academy of Sciences.

[13]  Emily B Fabyanic,et al.  Nondestructive, base-resolution sequencing of 5-hydroxymethylcytosine using a DNA deaminase , 2018, Nature Biotechnology.

[14]  M. Benson,et al.  A reassessment of DNA-immunoprecipitation-based genomic profiling , 2017, Nature Methods.

[15]  N. Heintz,et al.  5-hydroxymethylcytosine accumulation in postmitotic neurons results in functional demethylation of expressed genes , 2017, Proceedings of the National Academy of Sciences.

[16]  A. Bird,et al.  MeCP2 recognizes cytosine methylated tri-nucleotide and di-nucleotide sequences to tune transcription in the mammalian brain , 2017, PLoS genetics.

[17]  Harrison W. Gabel,et al.  DNA methylation in the gene body influences MeCP2-mediated gene repression , 2016, Proceedings of the National Academy of Sciences.

[18]  Lior Pachter,et al.  Near-optimal probabilistic RNA-seq quantification , 2016, Nature Biotechnology.

[19]  Cheng Luo,et al.  Structural insight into substrate preference for TET-mediated oxidation , 2015, Nature.

[20]  Wei Li,et al.  MeCP2 binds to non-CG methylated DNA as neurons mature, influencing transcription and the timing of onset for Rett syndrome , 2015, Proceedings of the National Academy of Sciences.

[21]  Harrison W. Gabel,et al.  Disruption of DNA methylation-dependent long gene repression in Rett syndrome , 2015, Nature.

[22]  W. Huber,et al.  Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2 , 2014, Genome Biology.

[23]  Guoping Fan,et al.  Distribution, recognition and regulation of non-CpG methylation in the adult mammalian brain , 2013, Nature Neuroscience.

[24]  Matthew D. Schultz,et al.  Global Epigenomic Reconfiguration During Mammalian Brain Development , 2013, Science.

[25]  Pinar Ayata Decoding 5HMC as an Active Chromatin Mark in the Brain and its Link to Rett Syndrome , 2013 .

[26]  Xiaodong Cheng,et al.  Recognition and potential mechanisms for replication and erasure of cytosine hydroxymethylation , 2012, Nucleic acids research.

[27]  A. Bird,et al.  Oxidative damage to methyl-CpG sequences inhibits the binding of the methyl-CpG binding domain (MBD) of methyl-CpG binding protein 2 (MeCP2). , 2004, Nucleic acids research.

[28]  A. Bird,et al.  Purification, sequence, and cellular localization of a novel chromosomal protein that binds to Methylated DNA , 1992, Cell.